Contact
Please use this form to send email to PR contact of this press release:
CNBX Selects API Supplier Purisys to Support Planned IND Fillings and Phase I/II (a) Clinical Trials
TO:
Eyal Barad
Cannabics Pharmaceuticals Inc.
+1 877424-2429